DEA and Morris & Dickson Announce Settlement

The Drug Enforcement Administration (DEA) recently announced a settlement with pharmaceutical distributor Morris & Dickson Co., LLC (Morris & Dickson) for failing to maintain effective controls against diversion of controlled substance, which included the failure to report thousands of unusually large orders of oxycodone and hydrocodone.

As part of the settlement last month, Morris & Dickson agreed to admit wrong doing and comply with the DEA’s heightened reporting requirements. Morris & Dickson also agreed to surrender one of its to certificates of registration with the DEA and forfeit $19 million to resolve this years-long administrative proceeding regarding violations of the Controlled Substances Act (CSA).

Baer Law works with DEA registrants to improve their CSA compliance programs and advises DEA registrants in governmental investigations and enforcement actions.